18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.Tools Beheshti, Mohsen und Hehenwarter, Lukas und Paymani, Zeinab und Rendl, Gundula und Imamovic, Larisa und Rettenbacher, Rupert und Tsybrovskyy, Oleksiy und Langsteger, Werner und Pirich, Christian (2018) 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. European Journal of Nuclear Medicine and Molecular Imaging, 45 (10). pp. 1762-1771. ![[thumbnail of 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.]](https://eprints.vinzenzgruppe.at/style/images/fileicons/text.png "18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.")
Text (18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.)
2018 EJNMMI Beheshti Hehenwarter.pdf ['document_security_info' not defined] Nur registrierte Benutzer ['summary_page:download' not defined] (1MB)
|
||||||||||||||
|
|
|
Tools
Tools
